A detailed history of Ubs Group Ag transactions in Dexcom Inc stock. As of the latest transaction made, Ubs Group Ag holds 353,600 shares of DXCM stock, worth $31.2 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
353,600
Previous 434,000 18.53%
Holding current value
$31.2 Million
Previous $29.1 Million 5.46%
% of portfolio
0.01%
Previous 0.01%

Shares

32 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$65.68 - $81.01 $35.2 Million - $43.4 Million
535,372 Added 37.91%
1,947,686 $151 Million
Q3 2024

Nov 14, 2024

BUY
$64.0 - $116.06 $13.8 Million - $25 Million
215,023 Added 17.96%
1,412,314 $94.7 Million
Q2 2024

Aug 13, 2024

BUY
$110.31 - $140.45 $9.34 Million - $11.9 Million
84,628 Added 7.61%
1,197,291 $136 Million
Q1 2024

May 13, 2024

BUY
$114.22 - $140.1 $9.64 Million - $11.8 Million
84,435 Added 8.21%
1,112,663 $154 Million
Q4 2023

Feb 09, 2024

SELL
$75.49 - $124.16 $3.41 Million - $5.6 Million
-45,110 Reduced 4.2%
1,028,228 $128 Million
Q3 2023

Nov 09, 2023

BUY
$86.06 - $137.93 $10.9 Million - $17.5 Million
126,531 Added 13.36%
1,073,338 $100 Million
Q2 2023

Aug 11, 2023

BUY
$112.47 - $130.98 $37.7 Million - $43.9 Million
335,383 Added 54.85%
946,807 $122 Million
Q1 2023

May 12, 2023

SELL
$104.0 - $122.92 $5.69 Million - $6.72 Million
-54,676 Reduced 8.21%
611,424 $71 Million
Q4 2022

Feb 08, 2023

BUY
$84.98 - $122.67 $27 Million - $38.9 Million
317,190 Added 90.91%
666,100 $75.4 Million
Q3 2022

Nov 10, 2022

SELL
$76.35 - $94.18 $7.09 Million - $8.75 Million
-92,903 Reduced 21.03%
348,910 $28.1 Million
Q2 2022

Aug 10, 2022

BUY
$67.99 - $132.89 $21.3 Million - $41.7 Million
313,591 Added 244.57%
441,813 $32.9 Million
Q1 2022

May 16, 2022

SELL
$94.08 - $130.2 $5.37 Million - $7.44 Million
-57,116 Reduced 30.82%
128,222 $65.6 Million
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $893,895 - $1.12 Million
6,883 Added 3.86%
185,338 $99.5 Million
Q3 2021

Nov 15, 2021

BUY
$106.71 - $143.18 $3.95 Million - $5.31 Million
37,055 Added 26.21%
178,455 $97.6 Million
Q2 2021

Aug 13, 2021

BUY
$80.99 - $107.93 $1.2 Million - $1.6 Million
14,795 Added 11.69%
141,400 $60.4 Million
Q1 2021

May 12, 2021

SELL
$84.79 - $104.74 $924,465 - $1.14 Million
-10,903 Reduced 7.93%
126,605 $45.5 Million
Q4 2020

Feb 11, 2021

BUY
$78.0 - $104.5 $2.37 Million - $3.17 Million
30,327 Added 28.3%
137,508 $50.8 Million
Q3 2020

Nov 12, 2020

BUY
$95.51 - $112.95 $1.39 Million - $1.65 Million
14,568 Added 15.73%
107,181 $44.2 Million
Q2 2020

Jul 31, 2020

BUY
$62.68 - $105.34 $393,943 - $662,061
6,285 Added 7.28%
92,613 $37.5 Million
Q1 2020

May 01, 2020

BUY
$47.79 - $75.63 $340,981 - $539,620
7,135 Added 9.01%
86,328 $23.2 Million
Q4 2019

Feb 14, 2020

BUY
$36.62 - $57.29 $593,756 - $928,900
16,214 Added 25.75%
79,193 $17.3 Million
Q3 2019

Nov 14, 2019

SELL
$35.53 - $43.8 $1.06 Million - $1.31 Million
-29,928 Reduced 32.21%
62,979 $9.4 Million
Q2 2019

Aug 14, 2019

SELL
$27.84 - $38.92 $551,928 - $771,589
-19,825 Reduced 17.59%
92,907 $13.9 Million
Q1 2019

May 14, 2019

BUY
$28.07 - $38.18 $1.47 Million - $2 Million
52,459 Added 87.04%
112,732 $13.4 Million
Q4 2018

Feb 14, 2019

BUY
$26.99 - $37.37 $851,966 - $1.18 Million
31,566 Added 109.96%
60,273 $7.22 Million
Q3 2018

Nov 14, 2018

BUY
$23.35 - $36.72 $240,808 - $378,693
10,313 Added 56.07%
28,707 $4.11 Million
Q2 2018

Aug 14, 2018

BUY
$17.54 - $25.22 $43,288 - $62,242
2,468 Added 15.5%
18,394 $1.75 Million
Q1 2018

May 15, 2018

BUY
$13.06 - $18.54 $89,983 - $127,740
6,890 Added 76.25%
15,926 $1.18 Million
Q4 2017

Feb 14, 2018

SELL
$11.12 - $15.38 $1.03 Million - $1.43 Million
-92,821 Reduced 91.13%
9,036 $519,000
Q3 2017

Nov 14, 2017

BUY
$11.36 - $18.98 $943,266 - $1.58 Million
83,034 Added 441.13%
101,857 $4.98 Million
Q2 2017

Aug 14, 2017

SELL
N/A
-1,494 Reduced 7.35%
18,823 $1.38 Million
Q1 2017

Nov 14, 2017

BUY
N/A
20,317
20,317 $1.72 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $34.1B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.